Ulf WIInberg - Sep 1, 2023 Form 4 Insider Report for MiNK Therapeutics, Inc. (INKT)

Role
Director
Signature
By: /s/ Christine Klaskin, Attorney-in-Fact
Stock symbol
INKT
Transactions as of
Sep 1, 2023
Transactions value $
$14,001
Form type
4
Date filed
9/6/2023, 05:00 PM
Previous filing
Jul 6, 2023
Next filing
Oct 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INKT Common Stock Award $14K +9.59K +18.98% $1.46 60.1K Sep 1, 2023 Direct F1, F2
holding INKT Common Stock 78.3K Sep 1, 2023 See footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date.
F2 In Table 1 of the Form 4 filed on June 2, 2023, the amount of securities acquired and price (column 4) and amount of securities beneficially owned following reported transaction (column 5) were erroneously reported. On June 1, 2023, 7,778 RSUs were acquired at a price of $1.80 each, resulting in a total amount of securities beneficially owned following the reported transaction of 50,529 instead of 50,706 as erroneously reported.
F3 Shares are held in an irrevocable trust for the benefit of Mr. Wiinberg's family.